Breaking News

WuXi STA to Build New R&D Center in Shanghai

One-site solution for APIs and advanced intermediates from preclinical and clinical development through to commercial launch

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

STA Pharmaceutical Co., Ltd., a subsidiary of WuXi AppTec (WuXi STA), has signed an investment agreement with the government of Shanghai, Jinshan District to build a new R&D center. The new facility will strengthen WuXi STA’s global pharmaceutical development and manufacturing platform, enabling drug developers to accelerate their projects from preclinical to commercial stage. The company has five sites in China and the U.S. The Jinshan site currently focuses on manufacturing active...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters